Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Ipilimumab × 30 days × Clear all

Sponsor

Conditions

Melanoma 13 Carcinoma, Renal Cell 12 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Squamous Cell Carcinoma of Head and Neck 4 Skin Neoplasms 4 Carcinoma, Transitional Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Merkel Cell 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Gliosarcoma 2 Glioma 2 Colorectal Neoplasms 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Carcinoma 2

Interventions

Fluorouracil 9 Oxaliplatin 8 Nivolumab 7 Leucovorin 7 Capecitabine 7 pembrolizumab 3 Trastuzumab 3 Specimen Handling 3 Paclitaxel 3 Cisplatin 3 zimberelimab 2 zanidatamab 2 dehydroftorafur 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Docetaxel 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 toripalimab 1 tislelizumab 1 quemliclustat 1 obeticholic acid 1 durvalumab 1 Taxes 1 Ramucirumab 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡